Interferon-gamma: Clinical Trials

19 trials of Interferon-gamma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 5 terminated, 1 unknown, 1 withdrawn. 19 Phase 1, 7 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 119Completed 12, Terminated 5, Unknown 1, Withdrawn 1
Phase 27Completed 4, Terminated 2, Withdrawn 1

Follow Interferon-gamma: new trials by email Literature Review of Interferon-gamma trials Research Report on Interferon-gamma

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma
Albuterol Sulfate, Interferon gamma-primed mesenchymal stromal cells (MSCs), Prednisone - Asthma
Phase 1TerminatedEmory University12022-03-162025-06-03
Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease
Interferon gamma (IFNγ)-primed human bone marrow-derived mesenchymal stromal cells - Acute Leukemia, Myelodysplastic Syndromes
Phase 1TerminatedEdwin Horwitz42021-12-022026-02-13
Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer
Autologous MCPyV-specific HLA-A02-restricted TCR-transduced CD4+ and CD8+ T-cells FH-MCVA2TCR, Avelumab, Pembrolizumab - Other Skin
Phase 1 / Phase 2TerminatedFred Hutchinson Cancer Center72019-07-032025-03-06
Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer
Interferon-gamma (IFN-γ), Paclitaxel, Trastuzumab - Breast Cancer, Breast Cancer, Male
Phase 1 / Phase 2CompletedH. Lee Moffitt Cancer Center and Research Institute512017-06-232023-04-19
Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma
Multiple drug microinjection, CIVO device - Soft Tissue Sarcoma Adult
Phase 1CompletedPresage Biosciences232016-12-152021-09-24
Effect of IFN-γ on Innate Immune Cells
Administration of drug (Interferon-gamma 1-b) subcutaneously - Chronic Granulomatous Disease
Phase 1CompletedUniversity of Colorado, Denver202016-07-012019-02-15
Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors
interferon-gamma and nivolumab - Advanced Solid Tumors
Phase 1CompletedFox Chase Cancer Center262015-12-112019-11-29
DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
Single intratumoral injection of DNX-2401, Interferon-gamma - Glioblastoma or Gliosarcoma
Phase 1CompletedDNAtrix, Inc.372014-09-112018-07-16
Determining the Effect of Actimmune (Interferon Gamma 1b)Dose Titration on Flu-Like Symptoms in Healthy Volunteers
interferon gamma 1b - Adverse Effects in the Therapeutic Use of Interferon
Phase 1UnknownVidara Therapeutics Research Ltd402013-07-012013-08-28
The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon Gamma
Interferon Gamma 1-b - Uveitis
Phase 1CompletedNational Eye Institute (NEI)52009-07-172017-07-02
HGS-ETR2 to Treat Children With Solid Tumors
Lexatumumab alone, Lexatumumab in combination, Interferon gamma 1b in combination - Ewing's Sarcoma, Osteosarcoma
Phase 1TerminatedNational Cancer Institute (NCI)302006-12-042019-12-17
Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis
Interferon-Gamma - HIV Coinfection, Aids/Hiv Problem
Phase 1 / Phase 2CompletedSPP Pharmaclon Ltd.782006-01-192024-01-25
Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex Infection
Cytokine therapy, Interferon Gamma, GM-CSF - Mycobacterium Avium-Intracellulare Infection
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)22005-05-132017-07-02
ITV Extension Study
recombinant fowlpoxvirus (rFPV) expressing HIV gag-pol antigens, HIV gag-pol antigens and interferon-gamma (IFN-y) - HIV
Phase 1 / Phase 2CompletedKirby Institute352002-09-012007-02-27
Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors
recombinant interferon gamma - Melanoma (Skin), Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedUniversity of Rochester1999-04-012013-06-06
Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer
ALVAC-hB7.1, recombinant interferon gamma, laboratory biomarker analysis - Recurrent Ovarian Epithelial Cancer
Phase 1CompletedNational Cancer Institute (NCI)121997-10-012013-01-23
Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer
fluorouracil, sodium phenylbutyrate, indomethacin - Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum
Phase 1 / Phase 2TerminatedNational Cancer Institute (NCI)461997-05-012013-02-01
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
filgrastim, recombinant interferon gamma, busulfan - Leukemia
Phase 1 / Phase 2WithdrawnColumbia University1996-02-012012-11-19
Biological Therapy in Treating Patients With Prostate Cancer
aldesleukin, gene-modified tumor cell vaccine therapy, recombinant interferon gamma - Prostate Cancer
Phase 1 / Phase 2CompletedMemorial Sloan Kettering Cancer Center251995-01-012013-06-25

Conditions studied

Neoplasm Metastasis (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Asthma (1)  ·  Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Breast Neoplasms, Male (1)  ·  Carcinoma, Merkel Cell (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Colonic Neoplasms (1)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  Gliosarcoma (1)  ·  Graft vs Host Disease (1)

Sponsors

National Cancer Institute (NCI) (3)  ·  Columbia University (1)  ·  DNAtrix, Inc. (1)  ·  Edwin Horwitz (1)  ·  Emory University (1)  ·  Fox Chase Cancer Center (1)  ·  Fred Hutchinson Cancer Center (1)  ·  H. Lee Moffitt Cancer Center and Research Institute (1)  ·  Kirby Institute (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  National Eye Institute (NEI) (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Presage Biosciences (1)  ·  SPP Pharmaclon Ltd. (1)  ·  University of Colorado, Denver (1)

Countries

United States (16)  ·  Australia (1)  ·  Russia (1)

Top investigators

Crystal L Mackall, M.D. (1)  ·  Daniel R. Ambruso, MD (1)  ·  David A Cooper, AO DSc MD FRACP FRCPA FRCP (1)  ·  Edwin Horwitz, MD (1)  ·  Edwin Horwitz, MD, PhD (1)  ·  Frederick Lang, MD (1)  ·  Gary Deutsch, MD (1)  ·  Gwen L. Nichols, MD (1)  ·  Joseph D. Rosenblatt, MD (1)  ·  Joshua Veatch (1)  ·  Karen Fink, MD, PhD (1)  ·  Kenneth Gundle, MD (1)  ·  Mark Matson, MD (1)  ·  Matthew Zibelman, MD (1)

Results publications

PMID 23071222, PMID 24576196, PMID 32299817, PMID 35113934, PMID 35880940, PMID 37500647, PMID 42715345

NIH funding

P01CA225517 (1), P30CA011198 (1), U01CA062461 (1), UL1TR001082 (1)